The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Stock and Other Ownership Interests - Bexion
Patents, Royalties, Other Intellectual Property - Bexion Pharmaceitucals
BXQ-350: A phase 1b/2 placebo controlled, double blinded study on the efficacy and safety of BXQ-350 in combination with mFOLFOX7 and bevacizumab in newly diagnosed metastatic colorectal carcinoma (mCRC).
 
Reema Anil Patel
Honoraria - Onc Live
Research Funding - Genentech (Inst); Ipsen (Inst)
Travel, Accommodations, Expenses - Genentech
 
Ari David Baron
No Relationships to Disclose
 
Brian C. Boulmay
No Relationships to Disclose
 
Daniel Blake Flora
No Relationships to Disclose
 
Julie Anne L Gemmill
No Relationships to Disclose
 
Fa Chyi Lee
No Relationships to Disclose
 
Davendra Sohal
Honoraria - Foundation Medicine
Consulting or Advisory Role - AADi; Ability Pharma; AstraZeneca/MedImmune; Bayer; Elevar Therapeutics; Totus Medicines; TransThera Sciences (Nanjing), Inc.; Valar Labs
Speakers' Bureau - AstraZeneca; Genentech; Incyte; Seagen
Research Funding - Ability Pharma (Inst); Amgen (Inst); Apexigen (Inst); Astellas Pharma (Inst); AstraZeneca/MedImmune (Inst); Bexion (Inst); Bristol-Myers Squibb (Inst); FibroGen (Inst); Genentech (Inst); Hengrui Therapeutics (Inst); Merck (Inst); Mirati Therapeutics (Inst); NextCure (Inst); Regeneron (Inst); Replimune (Inst); Roche (Inst); Triumvira Immunologics, Inc (Inst)
Travel, Accommodations, Expenses - Ability Pharma
 
Grant Richard Williams
Honoraria - Cardinal Health
Speakers' Bureau - Cardinal Health
 
Richard Charles Curry
Stock and Other Ownership Interests - Bexion
 
Michael Gazda
No Relationships to Disclose
 
Joseph D. Purvis
Stock and Other Ownership Interests - Abbvie; BMSi; Merck
Consulting or Advisory Role - Bexion; Gandeeva Pharmaceuticals; Linical Americas
Travel, Accommodations, Expenses - Bexion
 
Gilles Tapolsky
Employment - Bexion
Stock and Other Ownership Interests - Bexion
Honoraria - UNandUp
Research Funding - Bexion
Patents, Royalties, Other Intellectual Property - Bexion
 
Ray Takigiku
Employment - Bexion
Leadership - Bexion
Stock and Other Ownership Interests - Bexion
Patents, Royalties, Other Intellectual Property - Patents related to technology owned by Bexion Pharmaceuticals